| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/2005 | EP1529845A2 Fusion glycoprotein from HCMV and HSV |
| 05/11/2005 | EP1529784A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate-palmitoleate. |
| 05/11/2005 | EP1529535A1 Isolation of a circulating human lipolytic peptide |
| 05/11/2005 | EP1529534A2 Use of GLP-1 peptides |
| 05/11/2005 | EP1529533A1 Use of GH secretagogues in hypoxic-ischemic brain injury |
| 05/11/2005 | EP1529529A1 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for immunomodulation, immunostimulation and/or antiphlogistic treatment |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529108A2 Albumin-fused ciliary neurotrophic factor |
| 05/11/2005 | EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529061A1 Method for isolating an intestinal cholesterol binding protein |
| 05/11/2005 | EP1529059A2 Porcine leptin protein, antisense and antibody |
| 05/11/2005 | EP1529057A2 Biphalin derivatives and their analgesic applications |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1528931A1 Methods for improving islet signaling in diabetes mellitus and for its prevention |
| 05/11/2005 | EP1528930A1 Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin |
| 05/11/2005 | EP1528929A1 Novel use of lipopeptide preparations |
| 05/11/2005 | EP1528928A2 Methods and compositions for modulating beta-catenin phosphorylation |
| 05/11/2005 | EP1528922A1 Use of treosulfan and derivatives thereof for treating multiple sclerosis |
| 05/11/2005 | EP1528915A2 Liposomal vaccine |
| 05/11/2005 | EP1528894A2 Biomatrix structural containment and fixation systems and methods of use thereof |
| 05/11/2005 | EP1409508A4 Mammalian neuralized family transcriptional regulators and uses therefor |
| 05/11/2005 | EP1390399B1 Long lasting fusion peptide inhibitors for hiv infection |
| 05/11/2005 | EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof |
| 05/11/2005 | EP1280531A4 Local anesthetic methods and kits |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP1161153B1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP1100771B1 Compounds and compositions for delivering active agents |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1076563B1 Dipeptide caspase inhibitors and the use thereof |
| 05/11/2005 | EP1036092B1 Hydrophobically-modified hedgehog protein compositions and methods |
| 05/11/2005 | EP1019072B1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 05/11/2005 | EP0987943B1 Detecting and treating cancer |
| 05/11/2005 | EP0986408B1 New medicaments based on polymers composed of methacrylamide-modified gelatin |
| 05/11/2005 | EP0944725B1 Phosphodiesterase 8 |
| 05/11/2005 | EP0894094B1 Process for extraction of a growth factor complex |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0572478B1 Hbgad and higad polypeptides and nucleic acids and their use for the diagnosis and treatment of gad autoantigen associated diseases |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615160A A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 05/11/2005 | CN1615154A Oral administration of interferon-TAU |
| 05/11/2005 | CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/11/2005 | CN1615151A Plasmid mediated suplementation for treating chronically ill subjects |
| 05/11/2005 | CN1615150A Assay for the detection of factors that modulate the expression of INGAP |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615147A Treatment of glioblastoma with thymosin-alpha 1 |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/11/2005 | CN1615143A Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1615131A Method for identification of tumor targeting enzymes |
| 05/11/2005 | CN1615127A Substituted bicyclo[3.3.1]nonan-2, 4, 9-triones as pharmaceutical active ingredients |
| 05/11/2005 | CN1614028A Dried bacterial powder process containing gamma-linolenic acid |
| 05/11/2005 | CN1613872A Interferon of IFN-beta-cn and its mutant |
| 05/11/2005 | CN1201011C Heterologous expression of neisserial proteins |
| 05/11/2005 | CN1201009C Histidine protein-phosphatase |
| 05/11/2005 | CN1201006C High-affinity interleukin-4 muteins |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/11/2005 | CN1200949C Covalently bridged insulin dimers |
| 05/11/2005 | CN1200947C Method for producing cyclo-(Asp-Dphe-NMeVal-Arg-Gly) |
| 05/11/2005 | CN1200946C Process for preparation of N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 05/11/2005 | CN1200733C Reversal of viral-induced systemic shock and respiratory distress by blockade of lymphotoxin beta pathway |
| 05/11/2005 | CN1200729C Vaginal-applied interferon table and its preparing process |
| 05/11/2005 | CN1200728C Injection-type bone morphogenetic protein using fibrin as carrier |
| 05/11/2005 | CN1200727C Pharmaceutical compositions based on alpha-cyclodextrin for oral administratio nof LH-RH analogues |
| 05/11/2005 | CN1200726C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/11/2005 | CN1200707C New use of taxoid derivatives |
| 05/11/2005 | CN1200698C Use of corneal hardening agent in enzyme orthokeratology |
| 05/10/2005 | US6892140 Immunogenic cancer peptides and uses thereof |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6891025 Capable of being crystallized without complexing to a ligand; human growth hormone receptor (hGHR) |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/10/2005 | US6890948 With an electron withdrawing substituent; Treating neoplastic diseases in methods of GDEPT, ADPET, PDEPT, VDEPT, and PDT; tissue-directed prodrug therapy |
| 05/10/2005 | US6890945 Administering a imidazo(4,5,1-ij)quinoline compound |
| 05/10/2005 | US6890918 Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers |
| 05/10/2005 | US6890910 Murd protein and gene of Pseudomonas aeruginosa |
| 05/10/2005 | US6890909 Containing an NF-kappa B decoy; compound which specifically antagonizes the NF-kappa B binding sites; encephalopathy; diminishing a cerebral vasospasm associated with a subarachnoid hemorrhage; liposomal delivery of an |
| 05/10/2005 | US6890908 Modified ribozymes |
| 05/10/2005 | US6890904 An antiangiogenic, anticancer, and an antiproliferative which inhibits the enzyme fibroblast activation protein-alpha (FAP-alpha); peptides with reactive analog of proline where the COOH is replaced by a boronyl group (B(OH)2); val-boro-pro |
| 05/10/2005 | US6890903 Prevention accumulation of fluid at site of injury, surgery |
| 05/10/2005 | US6890902 Cytotoxic modified lactoferrin peptides |
| 05/10/2005 | US6890901 Hyaluronic drug delivery system |
| 05/10/2005 | US6890900 Methods for treating or preventing diseases of the oral cavity |
| 05/10/2005 | US6890899 A lipolytic or lipid mobilising factor (LMF) produced by the cachexia-inducing murine tumor MAC16; weight reduction or controlling obesity; administering a Zn-alpha 2-glycoprotein |
| 05/10/2005 | US6890898 Method of regulating glucose metabolism, and reagents related thereto |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890896 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses |
| 05/10/2005 | US6890738 Prolactin antagonists and uses thereof |